UBS AM Boosts Stake in Amgen

UBS AM, a distinct business unit of UBS Asset Management Americas LLC, has increased its stake in Amgen Inc. (NASDAQ:AMGN) by 12.7% during the second quarter.

The firm now owns 5,390,910 shares of the medical research company's stock after purchasing an additional 605,928 shares during the period.

This represents about 1.00% of Amgen's outstanding shares and a total value of $1,952,156,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of AMGN, including Toth Financial Advisory Corp, Mufg Securities Americas Inc., Nissay Asset Management Corp Japan, Field & Main Bank, and Wellington Management Group LLP.